# Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Source: https://welltoldgrants.com/grants/cdc-rfa-ps-27-0009-integrated-viral-hepatitis-surveillance-testing-treatment/  
Official notice: https://www.grants.gov/search-results-detail/362731

> Centers for Disease Control - NCHHSTP plans to offer grants to state and local governments. It expects to make about 60 awards worth $450 million in total. It is a forecast: the notice is expected around December 1, 2026, with applications due around February 16, 2027.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-PS-27-0009 |
| Agency | Centers for Disease Control - NCHHSTP |
| Status | Forecast |
| Deadline | expected February 16, 2027 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 60 |
| Total funding | $450 million |
| Cost sharing | not required |
| Assistance Listings | 93.270 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.

## What the grant funds

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings. This multi-component NOFO includes two required components and two optional components: Component 1: Outbreak Response and Surveillance (Required) Component 2: Planning, Partnerships, and Promotion (Required) Component 3: Testing, Treatment, and Prevention (Optional) Component 4: Perinatal Hepatitis C Program (Optional) This NOFO is alignment with CDC priorities.

## Questions people ask

### Who can apply for Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)?

Centers for Disease Control - NCHHSTP accepts applications from state and local governments. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)?

Expected deadline February 16, 2027. Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

About $450 million in total across about 60 awards.